Neauvia is pleased to announce that it will be exhibiting at the Aesthetics Conference & Exhibition (ACE) 2026, one of the UK’s leading events for medical aesthetics professionals.
Taking place at the Business Design Centre in London, ACE brings together practitioners, brands and innovators from across the aesthetics industry for two days of education, networking and discovery.
Whether you are looking to elevate patient outcomes, expand your treatment offering, or explore advanced aesthetic technologies, the Neauvia team will be on hand throughout the event to guide you.
ACE is almost here and the Neauvia team is looking forward to welcoming visitors to Stand E3.
Attendees will have the opportunity to explore the brand’s latest technologies, products and protocols, as well as gain valuable insights from experienced practitioners.
Visitors to the stand can expect:
• Live masterclasses
• Device demonstrations
• PEG filler education
• Exclusive event offers
If you are attending ACE, be sure to add Neauvia to your must-visit list.
Throughout the event, Neauvia will host a series of live masterclasses and demonstrations, designed to showcase advanced treatment techniques and combination protocols.
These sessions provide practitioners with the opportunity to learn directly from experienced clinicians and see how innovative technologies can be integrated into clinical practice.
To learn more about the masterclass schedule or reserve your place, contact the Neauvia team.
Alongside its presence at ACE, Neauvia is also highlighting the findings of a newly published independent study that examines how hyaluronic acid fillers should be evaluated.
Published in the Journal of Colloid and Interface Science, the study analysed 24 commercial hyaluronic acid fillers using a comprehensive mechanical framework.
Traditionally, filler performance has often been assessed using G’ (elastic modulus) as a primary metric. However, this research argues that relying on a single parameter provides only a limited view of product performance.
Instead, the study evaluated multiple mechanical and structural factors, including:
• Crossover strain
• Cohesion
• Recovery after stress
• Resistance to enzymatic degradation
By analysing these parameters together, researchers were able to develop a more complete understanding of how fillers perform in real-world clinical settings.
Within the study’s analysis, PEGDE-based fillers – including Neauvia products – demonstrated strong performance across several key indicators.
These fillers showed:
• High crossover strain
• Strong cohesion
• Excellent recovery following stress
• Notable structural resilience
The research highlights a growing shift in the aesthetics industry toward evidence-based product evaluation, moving beyond single-number comparisons to consider a broader set of mechanical and structural characteristics.
The publication provides valuable insights for practitioners seeking a deeper understanding of filler behaviour and the science behind product performance.